New Jersey Business NJ

Organon to acquire Finland pharma company with novel treatment for endometriosis in its pipeline

Return On Information New Jersey

Nov 12, 2021

Global health care company - and Merck spinoff - Organon will acquire Finland-based Forendo Pharma, according to a joint Thursday announcement. The transaction includes a $75 milli…

Read the full story at Return On Information New Jersey

Topics

#Finland

Organon to acquire Finland pharma company with novel treatment for endometriosis in its pipeline

Topics

More from New Jersey Business

Statement: Sherrill administration should have delayed New Jersey's new independent contractor regulations

New Report Says N.J. Needs More Affordable Homes for Sale, Not Just Buyer Assistance

100,000 Square Foot Expansion Breaks Ground at Liberty Science Center

Panoramic Manhattan Views and a Private Terrace Define This Avora Residence

New Jersey cannot afford to send mixed signals to business

Team Moza Debuts Casa One, Featuring 196 Rental Residences in Journal Square

Princeton Community Housing to Build Affordable Apartments on Former DPW Site

All-Affordable 113-Unit Development Moves Forward in Wayne